Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment. J of Skin [Internet]. 2019 Sep. 13 [cited 2026 May 4];3(5):291-306. Available from: https://skin.dermsquared.com/skin/article/view/663